Close Menu
    What's Hot

    On August 5, China Implements Stricter Drone Export Restrictions Amid US Countermeasures

    August 6, 2026

    Immune Mediated Disease Therapeutics Developer Attovia Therapeutics Debuts on Nasdaq

    August 6, 2026

    UnionPay International and Pesapal Partner to Boost Cross-Border Payments and Tourism in East Africa

    August 6, 2026
    Facebook X (Twitter) Instagram
    Trending
    • On August 5, China Implements Stricter Drone Export Restrictions Amid US Countermeasures
    • Immune Mediated Disease Therapeutics Developer Attovia Therapeutics Debuts on Nasdaq
    • UnionPay International and Pesapal Partner to Boost Cross-Border Payments and Tourism in East Africa
    • LG ELECTRONICS INVITES THE WORLD TO EXPERIENCE “INNOVATION IN TUNE WITH YOU” AT IFA 2026
    • Mitrade Wins 2026 AI Broker of the Year as It Upgrades MitradeGPT in MENA
    • Diego Mesa Puyo selected as next GEF CEO and Chairperson
    • Envision and Sasol Advance Future Energy Systems with Green Hydrogen Collaboration in South Africa
    • July sees Eurozone manufacturing output reach highest level in 52 months despite sluggish demand
    • Home
    • Contact Us
    Giza Mail: Egypt’s news, delivered with context.Giza Mail: Egypt’s news, delivered with context.
    Thursday, August 6
    • Automotive
    • Business
    • Entertainment
    • Health
    • Lifestyle
    • Luxury
    • News
    • More
      • Sports
      • Technology
      • Travel
    Giza Mail: Egypt’s news, delivered with context.Giza Mail: Egypt’s news, delivered with context.
    Home»PR Newswire
    PR Newswire

    FutureCeuticals, Inc. and Global Calcium Pvt., Ltd. Announce Strategic Partnership

    November 25, 2024

    MOMENCE, Ill., Nov. 25, 2024 /PRNewswire/ — FutureCeuticals, Inc. and Global Calcium Pvt., Ltd. announced today a strategic global sales and manufacturing partnership to expand FutureCeuticals’ portfolio of clinically proven dietary supplement ingredients into high-growth markets in India, Southeast Asia, the Middle East, and Africa. This partnership leverages Global Calcium’s manufacturing and sales network, opening new opportunities in these rapidly growing regions.

    The partnership will initially focus on FruiteX-B® calcium fructoborate, a patented and clinically supported mineral complex developed by FutureCeuticals, recognized as a leading solution for joint, mobility, and bone health products. By capitalizing on Global Calcium’s position in this market, FruiteX-B will offer new opportunities in these regions. Global Calcium’s expertise in calcium-based minerals will help expand FruiteX-B’s reach and strengthen its global presence in the mineral supplement category.

    “We are excited to partner with Global Calcium, extending the reach of our innovative ingredient solutions,” said J. Randal Wexler, Vice President and Head of Research & Development at FutureCeuticals. “Their world-class manufacturing capabilities align with our high standards, and this opens doors to some of the world’s fastest-growing markets. The decision to utilize their capabilities to help us globalize our industry-leading and innovative joint and bone mineral complex made perfect sense.”

    Sahil Vaz, Global Calcium’s CEO, echoed Mr. Wexler’s sentiment. “We are excited to collaborate with a globally recognized innovator like FutureCeuticals on this strategic venture. Their science-based platform of research-backed ingredients align perfectly with our manufacturing capabilities and business strengths.” Mr. Vaz called out FruiteX-B® specifically, sharing, “our initial focus on FutureCeuticals’ FruiteX-B calcium fructoborate provides a compelling new joint and bone solution that is a natural extension of our existing, market-leading specialty mineral actives offerings.”

    For sales inquiries regarding FruiteX-B® Calcium Fructoborate in India, Southeast Asia, the Middle East, and Africa, contact: info@globalcalcium.com. For inquiries in North America, Europe, China, and Australia, contact: sales@futureceuticals.com

    About FutureCeuticals, Inc.
    FutureCeuticals, Inc. is a leader in the research, development and manufacture of plant-based powders and extracts for the functional food, beverage, and dietary supplement markets.

    About Global Calcium Pvt., Ltd.
    Global Calcium, based in Bangalore, India, is a leader in API, drug, and dietary ingredient manufacturing, and offers best-in-class manufacturing standards that serve the world’s largest companies with a focus on supplying specialty and organic minerals-based products.

    Cision View original content:https://www.prnewswire.co.uk/news-releases/futureceuticals-inc-and-global-calcium-pvt-ltd-announce-strategic-partnership-302314609.html

    FutureCeuticals, Inc. and Global Calcium Pvt., Ltd. Announce Strategic Partnership

    Keep Reading

    Immune Mediated Disease Therapeutics Developer Attovia Therapeutics Debuts on Nasdaq

    UnionPay International and Pesapal Partner to Boost Cross-Border Payments and Tourism in East Africa

    LG ELECTRONICS INVITES THE WORLD TO EXPERIENCE “INNOVATION IN TUNE WITH YOU” AT IFA 2026

    Mitrade Wins 2026 AI Broker of the Year as It Upgrades MitradeGPT in MENA

    Diego Mesa Puyo selected as next GEF CEO and Chairperson

    Envision and Sasol Advance Future Energy Systems with Green Hydrogen Collaboration in South Africa

    Latest News

    On August 5, China Implements Stricter Drone Export Restrictions Amid US Countermeasures

    August 6, 2026

    July sees Eurozone manufacturing output reach highest level in 52 months despite sluggish demand

    August 5, 2026

    EU Unveils Scaleup Europe Fund with €5 Billion Goal in 2023

    August 5, 2026

    September 14 Marks the Inaugural WTO Trade and Technology Day Emphasizing Inclusive AI Policies

    August 5, 2026

    Inflation in OECD Countries Eases to 4.2% in June 2026 Amid Declining Energy Prices

    August 5, 2026

    Guatemala issues maximum alert status as Fuego volcano erupts on Monday

    August 5, 2026

    As of August 2023, Moderna Initiates Ebola Vaccine Phase 1 Trial Amid Ongoing DR Congo Outbreak

    August 5, 2026

    As of August 2, 2026, EU Implements AI Content Labeling Regulations Across Member States

    August 4, 2026
    © 2026 Giza Mail | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.